Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04765072 · ClinicalTrials.gov registry record · NA
Expanding Rural Health Cancer Control Capacity
A NA study of Cancer, sponsored by Debra Friedman.
- Active
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 4
- Study locations
NCT04765072: Active NA study of Cancer, sponsored by Debra Friedman.
NCT04765072 is a NA study of Cancer that is active but no longer recruiting, run by Debra Friedman. The registered enrollment target is 33 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04765072, a NA study of Cancer, is active but no longer recruiting, sponsored by Debra Friedman.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 4
- Study locations
Study Summary
Through this pilot study, investigators will test an innovative approach to implement survivorship care planning at three sites located in or adjacent to rural counties. The pilot data will inform a subsequent multi-site Hybrid Type 3 Implementation-Effectiveness study that will assess both implementation and clinical effectiveness outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Survivorship Patient Navigation Intervention
- BEHAVIORAL Telehealth Survivorship Visit Intervention
Study Locations (4)
Mississippi
- Baptist Cancer Center- Golden Triangle Columbus - Columbus
- Baptist Cancer Center - North Mississippi - Oxford
Tennessee
- Baptist Cancer Center- Bartlett - Bartlett
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-02-26 |
| Est. Completion | 2029-02 |
| Phase | NA |
What the registry record for NCT04765072 still lists
NCT04765072 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Survivorship Patient Navigation Intervention is the first listed.
NCT04765072 reports a single indexed study location in Mississippi, Tennessee.
Frequently Asked Questions
What is clinical trial NCT04765072 about?
NCT04765072 is a clinical study titled "Expanding Rural Health Cancer Control Capacity". Through this pilot study, investigators will test an innovative approach to implement survivorship care planning at three sites located in or adjacent to rural counties. The pilot data will inform a subsequent multi-site Hybrid Type 3 Implementation-Effectiveness study that will assess both implemen...
What is the current status of trial NCT04765072?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 33 participants. The study started on 2021-02-26. Estimated completion is 2029-02.
What conditions does trial NCT04765072 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT04765072?
The interventions under investigation include: Survivorship Patient Navigation Intervention (BEHAVIORAL), Telehealth Survivorship Visit Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04765072?
This trial is sponsored by Debra Friedman, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04765072 being conducted?
This trial has 4 study locations across Mississippi, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04765072's enrollment target sits among peer trials
33 495th of 615 higher than 120 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI